Growing Awareness and Increasing Government Initiatives to Boost Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market
The continuous research and development in the field of non-small cell lung cancer has helped the medical fraternity develop new drugs for targeting specific types of changes that cancer brings in. Non-small cell lung cancer (NSCLC), which is the second most common type of cancer seen across the globe, is also being studied for developing better therapies. It is also the most dangerous form of cancer, as it metastasizes into tissues and bones, leaving barely any time for reaction. The...
View full press release